New treatments for nervous disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5375 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2321157

This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.

La présente invention concerne le traitement de troubles de la toxicomanie, de troubles liés à l'utilisation de substances psychotropes, de troubles liés à l'intoxication, de troubles liés à l'inhalation, de l'alcoolisme, du tabagisme et de la dépendance à la nicotine ainsi que de troubles de l'hyperactivité avec déficit d'attention. Ce traitement consiste à administrer au patient une dose thérapeutiquement efficace, non toxique, de reboxetine et de ses dérivés et/ou de sels pharmaceutiquement acceptables de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New treatments for nervous disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New treatments for nervous disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New treatments for nervous disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1498206

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.